Needed: new and better tools to combat latent tuberculosis infection.

about

Is the large simple trial design used for comparative, post-approval safety research? A review of a clinical trials registry and the published literature.

P2860

Q37924275-613731C2-D588-4B56-A36A-CC150EA789A2

P2860

Needed: new and better tools to combat latent tuberculosis infection.

Item

http://www.wikidata.org/entity/Q42859871

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Needed: new and better tools to combat latent tuberculosis infection.

@en

Needed: new and better tools to combat latent tuberculosis infection.

@nl

type

Item

label

Needed: new and better tools to combat latent tuberculosis infection.

@en

Needed: new and better tools to combat latent tuberculosis infection.

@nl

prefLabel

Needed: new and better tools to combat latent tuberculosis infection.

@en

Needed: new and better tools to combat latent tuberculosis infection.

@nl

P1476

Needed: new and better tools to combat latent tuberculosis infection.

@en

P2093

Henry M Blumberg

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society

Update on the treatment of tuberculosis and latent tuberculosis infection

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?

Update on rifampin and rifabutin drug interactions.

Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.

New approaches to the treatment of latent tuberculosis.

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.

P304

761-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.7326/0003-4819-149-10-200811180-00011

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19017594

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

3844291

http://www.w3.org/2001/XMLSchema#string

Needed: new and better tools to combat latent tuberculosis infection.

about

P2860

P2860

Needed: new and better tools to combat latent tuberculosis infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932